{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T18:33:47Z","timestamp":1763318027720},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T00:00:00Z","timestamp":1321401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s00774-011-0326-0","type":"journal-article","created":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T12:36:15Z","timestamp":1321360575000},"page":"359-366","source":"Crossref","is-referenced-by-count":5,"title":["Osteoporosis Patient Treatment Satisfaction Questionnaire in postmenopausal women intermittently treated with oral bisphosphonates: the BRAVO study"],"prefix":"10.1007","volume":"30","author":[{"name":"BRAVO (Osteoporosis and Bisphosphonates outcomes ReseArch Via questiOnnaire) Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Won","family":"Oh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deog-Yoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yil-Seob","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moo Il","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,16]]},"reference":[{"key":"326_CR1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bone.2011.03.719","volume":"48","author":"PN Sambrook","year":"2011","unstructured":"Sambrook PN, Silverman SL, Cauley JA, Recknor C, Olson M, Su G, Boonen S, Black D, Adachi JD, HORIZON Pivotal Fracture Trial (2011) Health-related quality of life and treatment of postmenopausal osteoporosis: results from the HORIZON-PFT. Bone 48:1298\u20131304","journal-title":"Bone"},{"issue":"10","key":"326_CR2","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00198-010-1495-8","volume":"22","author":"J Iwamoto","year":"2011","unstructured":"Iwamoto J, Makita K, Sato Y, Takeda T, Matsumoto H (2011) Alendronate is more effective than elcatonin in improving pain and quality of life in postmenopausal women with osteoporosis. Osteoporos Int 22(10):2735\u20132742","journal-title":"Osteoporos Int"},{"key":"326_CR3","first-page":"206","volume":"67","author":"H Ohbayashi","year":"2009","unstructured":"Ohbayashi H (2009) Examination of beneficial effects of risedronate in improving quality of life during long-term treatment of primary osteoporosis. Nippon Rinsho 67:206\u2013212","journal-title":"Nippon Rinsho"},{"key":"326_CR4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/qjmed\/hcn130","volume":"102","author":"S Rietbrock","year":"2009","unstructured":"Rietbrock S, Olson M, van Staa TP (2009) The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates. QJM 102:35\u201342","journal-title":"QJM"},{"key":"326_CR5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1359\/jbmr.080510","volume":"23","author":"AM Gallagher","year":"2008","unstructured":"Gallagher AM, Rietbrock S, Olson M, van Staa TP (2008) Fracture outcomes related to persistence and compliance with oral bisphosphonates. J Bone Miner Res 23:1569\u20131575","journal-title":"J Bone Miner Res"},{"key":"326_CR6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4065\/81.8.1013","volume":"81","author":"ES Siris","year":"2006","unstructured":"Siris ES, Harris ST, Rosen CJ, Barr CE, Arvesen JN, Abbott TA, Silverman S (2006) Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. Mayo Clin Proc 81:1013\u20131022","journal-title":"Mayo Clin Proc"},{"key":"326_CR7","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00198-008-0829-2","volume":"20","author":"O Sheehy","year":"2009","unstructured":"Sheehy O, Kindundu C, Barbeau M, LeLorier J (2009) Adherence to weekly oral bisphosphonate therapy: cost of wasted drugs and fractures. Osteoporos Int 20:1583\u20131594","journal-title":"Osteoporos Int"},{"key":"326_CR8","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00198-008-0586-2","volume":"19","author":"JA Sunyecz","year":"2008","unstructured":"Sunyecz JA, Mucha L, Baser O, Barr CE, Amonkar MM (2008) Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization. Osteoporos Int 19:1421\u20131429","journal-title":"Osteoporos Int"},{"key":"326_CR9","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1007\/s00198-006-0322-8","volume":"18","author":"JA Cramer","year":"2007","unstructured":"Cramer JA, Gold DT, Silverman SL, Lewiecki EM (2007) A systematic review of persistence and compliance with bisphosphonates for osteoporosis. Osteoporos Int 18:1023\u20131031","journal-title":"Osteoporos Int"},{"key":"326_CR10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","volume":"80","author":"RR Recker","year":"2005","unstructured":"Recker RR, Gallagher R, MacCosbe PE (2005) Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women. Mayo Clin Proc 80:856\u2013861","journal-title":"Mayo Clin Proc"},{"key":"326_CR11","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1007\/s00198-006-0166-2","volume":"17","author":"AJ Carr","year":"2006","unstructured":"Carr AJ, Thompson PW, Cooper C (2006) Factors associated with adherence and persistence to bisphosphonate therapy in osteoporosis: a cross-sectional survey. Osteoporos Int 17:1638\u20131644","journal-title":"Osteoporos Int"},{"key":"326_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1477-7525-4-42","volume":"4","author":"EM Flood","year":"2006","unstructured":"Flood EM, Beusterien KM, Green H, Shikiar R, Baran RW, Amonkar MM, Cella D (2006) Psychometric evaluation of the Osteoporosis Patient Treatment Satisfaction Questionnaire (OPSAT-Q), a novel measure to assess satisfaction with bisphosphonate treatment in postmenopausal women. Health Qual Life Outcomes 4:42","journal-title":"Health Qual Life Outcomes"},{"key":"326_CR13","unstructured":"National Health Insurance Corporation (2006) The National Health Insurance Statistical Yearbook, pp 566\u2013570"},{"key":"326_CR14","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1089\/jwh.2008.1064","volume":"18","author":"SL Bonnick","year":"2009","unstructured":"Bonnick SL, Silverman S, Tanner SB, Martens M, Bachmann G, Kohles JD, Civitelli R (2009) Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate. J Womens Health (Larchmt) 18:935\u2013943","journal-title":"J Womens Health (Larchmt)"},{"key":"326_CR15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/SMJ.0b013e31819ed0dd","volume":"102","author":"N Binkley","year":"2009","unstructured":"Binkley N, Martens MG, Silverman SL, Derman RJ, Greenwald M, Kohles JD, Bachmann GA (2009) Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonates. South Med J 102:486\u2013492","journal-title":"South Med J"},{"key":"326_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jbspin.2007.07.011","volume":"75","author":"P Hadji","year":"2008","unstructured":"Hadji P, Minne H, Pfeifer M, Bourgeois P, Fardellone P, Licata A, Devas V, Masanauskaite D, Barrett-Connor E (2008) Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: a randomized, crossover study (BALTO II). Joint Bone Spine 75:303\u2013310","journal-title":"Joint Bone Spine"},{"key":"326_CR17","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1185\/030079905X74862","volume":"21","author":"R Emkey","year":"2005","unstructured":"Emkey R, Koltun W, Beusterien K, Seidman L, Kivitz A, Devas V, Masanauskaite D (2005) Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO). Curr Med Res Opin 21:1895\u20131903","journal-title":"Curr Med Res Opin"},{"key":"326_CR18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00223-009-9294-y","volume":"85","author":"YS Chung","year":"2009","unstructured":"Chung YS, Lim SK, Chung HY, Lee IK, Park IH, Kim GS, Min YK, Kang MI, Chung DJ, Kim YK, Choi WH, Shong MH, Park JH, Byun DW, Yoon HK, Shin CS, Lee YS, Kwon NH (2009) Comparison of monthly ibandronate versus weekly risedronate in preference, convenience, and bone turnover markers in Korean postmenopausal osteoporotic women. Calcif Tissue Int 85:389\u2013397","journal-title":"Calcif Tissue Int"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0326-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-011-0326-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-011-0326-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:16:45Z","timestamp":1559110605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-011-0326-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,16]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["326"],"URL":"https:\/\/doi.org\/10.1007\/s00774-011-0326-0","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2011,11,16]]}}}